Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Uveal Melanoma With Liver Metastases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02913417
What this trial is testing

Yttrium90, Ipilimumab, & Nivolumab for Uveal Melanoma With Liver Metastases

Who this might be right for
Uveal MelanomaHepatic Metastases
David Minor, MD 26
Testing effectiveness (Phase 2)Study completedNCT01473004
What this trial is testing

SIR-Spheres® 90Y Microspheres Treatment of Uveal Melanoma Metastasized to Liver

Who this might be right for
Stage IV Uveal Melanoma
Thomas Jefferson University 48
Early research (Phase 1)Study completedNCT04812470
What this trial is testing

Hepatic Arterial Infusion of Autologous Tumor Infiltrating Lymphocytes in Patients With Melanoma and Liver Metastases

Who this might be right for
Metastatic Uveal MelanomaMetastatic Cutaneous Melanoma
Vastra Gotaland Region 8
Not applicableNo Longer AvailableNCT01728051
What this trial is testing

Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver

Who this might be right for
Metastatic Liver CancerOcular MelanomaCutaneous Melanoma
Delcath Systems Inc.
Not applicableLooking for participantsNCT07364474
What this trial is testing

Immune Response to Percutaneous Hepatic Perfusion With Melphalan for Ocular Melanoma Metastatic to the Liver

Who this might be right for
Uveal Melanoma
Massachusetts General Hospital 10
Early research (Phase 1)Study completedNCT03538028
What this trial is testing

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

Who this might be right for
Cervical CancerMicrosatellite Instability (MSI)-High Endometrial CancerGastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])+14 more
Incyte Biosciences International Sàrl 22
Testing effectiveness (Phase 2)Study completedNCT00661622
What this trial is testing

Halt Growth of Liver Tumors From Uveal Melanoma With Closure of Liver Artery Following Injection of GM-CSF

Who this might be right for
Uveal MelanomaLiver Metastases
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 53
Testing effectiveness (Phase 2)WithdrawnNCT04184518
What this trial is testing

Durvalumab (MEDI4736) Plus Cediranib in Patients With Metastatic Uveal Melanoma

Who this might be right for
Uveal MelanomaMetastatic Cancer
Grupo Español Multidisciplinar de Melanoma
Very early researchEnded earlyNCT00499733
What this trial is testing

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Not applicableStudy completedNCT01311466
What this trial is testing

Liver Transplantation and Uveal Malignant Melanoma

Who this might be right for
Uveal Malignant Melanoma
Oslo University Hospital 2